glp 1 agonists and inflammation Frontiers A newly published case series

Wegovy (semaglutide) Wegovy is a GLP-1 agonist with the active ingredient semaglutide

They are also administered at different doses and last for different durations

PSA: As high-demand GLP-1 drugs become harder to get, the FDA is warning consumers that counterfeit Ozempic may be in circulation

It is important to note that the efficacy of hormonal contraception, when used orally, decreases because of tirzepatide use

To address these limitations and improve evidence-based guidelines for clinical practice, large-scale prospective studies and standardised real-world analyses are required in the future

Case reports have indicated that development of severe or disabling arthralgia may occur after days or years following of DPP-4 inhibitor initiation